| 1 |
34853102 | ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19. | 2021 Dec 1 |
1 |
| 2 |
23464532 | Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin. | 2013 Aug |
2 |
| 3 |
23522182 | Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus. | 2013 Oct |
2 |
| 4 |
22943931 | Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clamp. | 2012 Nov |
3 |